New breast cancer drug aims to replace harsh chemo before surgery
NCT ID NCT07305246
Summary
This study is testing if a new drug called SHR-A1811, given alone or with hormone therapy, is better and safer than standard chemotherapy when used before surgery for early-stage breast cancer. It will involve 120 women with a specific type of breast cancer (HR-positive, HER2-low). The goal is to see if the new treatment can shrink tumors effectively with fewer side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.